Page last updated: 2024-09-03

citrate phosphate dextrose and gabexate

citrate phosphate dextrose has been researched along with gabexate in 1 studies

Compound Research Comparison

Studies
(citrate phosphate dextrose)
Trials
(citrate phosphate dextrose)
Recent Studies (post-2010)
(citrate phosphate dextrose)
Studies
(gabexate)
Trials
(gabexate)
Recent Studies (post-2010) (gabexate)
14613374353106

Protein Interaction Comparison

ProteinTaxonomycitrate phosphate dextrose (IC50)gabexate (IC50)
Solute carrier family 22 member 2Homo sapiens (human)0.9
Coagulation factor XHomo sapiens (human)4.61
PlasminogenHomo sapiens (human)0.431
Urokinase-type plasminogen activatorHomo sapiens (human)0.431
Serine protease hepsinHomo sapiens (human)0.383
Multidrug and toxin extrusion protein 1Homo sapiens (human)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimoto, S; Fujita, H; Hazama, Y; Kuhara, K; Moriyama, A; Nishimura, S; Ohtake, C; Sakuma, R1

Other Studies

1 other study(ies) available for citrate phosphate dextrose and gabexate

ArticleYear
Nafamostat mesilate, a noncalcium compound, as an anticoagulant, induces calcium-dependent haemolysis when infused with packed erythrocytes.
    Transfusion medicine (Oxford, England), 2012, Volume: 22, Issue:3

    Topics: Anticoagulants; Benzamidines; Calcium; Citrates; Citric Acid; Drug Evaluation, Preclinical; Edetic Acid; Erythrocyte Membrane; Erythrocytes; Flow Cytometry; Gabexate; Glucose; Guanidines; Hemoglobins; Hemolysis; Humans; In Vitro Techniques; Infusion Pumps; Infusions, Intravenous; L-Lactate Dehydrogenase; Membrane Lipids; Phosphatidylserines; Solutions

2012